Fig. 3From: Clinical and histopathological analyses of VEGF receptors peptide vaccine in patients with primary glioblastoma - a case seriesClinical course of enrolled patients. a Overall survival of four patients. At the time of analysis, Case 3 and 4 still had CR. b Progression-free survival of four patientsBack to article page